|
|
| MRD / Regn No. |
: 20260000555 |
Date |
: 23/06/2026 |
| Patient Name |
: Maya Banik |
Age & Gender |
: 57 Yrs. / Female |
| Contact No. |
: 7005182562 |
UHID |
: |
| Ht / Wt / BMI |
: |
BP S / BP D |
: |
| Allergies |
: NKA |
Referred By |
: |
| |
|
|
Subjective |
: |
DM NEWLY DIAGNOSED,POST MENOPAUSAL BLEEDING |
|
Objective |
: |
NONE |
|
Analysis |
: |
TYPE 2 DM |
|
Plan |
: |
START DPP4I SGLT2I,SEE ME IN 2 MONTHS |
|
| Salient Investigations |
: |
FASTING PLASMA GLUCOSE (FPG): 131 mg/dL | POST PRANDIAL GLUCOSE (2HPP): 166 mg/dL |
|
|
S# |
Generic (Trade) Name |
Route |
Dosage |
Usage |
Duration |
|
1 |
EMPAGLIFLOZIN 10 MG LINAGLIPTIN 5 MG GLYXAMBI 10/5 |
|
1-0-0 |
BEFORE FOOD
|
TILL NEXT VISIT |
| EMPAGLIFLOZIN MAY CAUSE GENITOURINARY INFECTION KEEP GENITAL AREA CLEAN | |
|
| |
|
|
|
| Refill :
0 / Substitution: |
|
|
| Education |
: |
| Next Visit |
: 22/Aug/2026 |
| Tests Suggested For Next Visit |
: FBS 2HPP BUN CR URINE MICROALBUMIN LIPID PROFILE CBC LFT |
| |
|
| |
|